Respiratory tract infectious disorder

Related records

Broader conditions (7)

• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Disease of primarily extrinsic mechanism
• Human disease
• Infectious disease
• Respiratory system disorder

Narrower conditions (70)

• Acute fibrinous and organizing pneumonia
• Acute interstitial pneumonia
• Adiaspiromycosis
• Anaerobic pneumonia
• Avian influenza
• Bacterial pneumonia
• Bronchiolocentric pattern of interstitial pneumonia
• Bronchopneumonia
• Chronic eosinophilic pneumonia
• Combined pulmonary fibrosis-emphysema syndrome
• Common cold
• Contagious pleuropneumonia
• Cork-handlers' disease
• Croup
• Cryptogenic organizing pneumonia
• Cytomegalovirus pneumonia
• Cytomegalovirus pneumonia due to NOS2 deficiency
• Desquamative interstitial pneumonia
• Eosinophilic pneumonia
• Follicular bronchiolits

Trials (741)

• 'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
• "Alcohol Based Hand Sanitizers for the Prevention of Acute Diarrheal Disease and Acute Respiratory Infection in Children Under 5 Attending Childcare Centers in Bogotá, Cundinamarca and Tolima, in Colombia: a Cluster Randomized Control Trial"
• A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness
• A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution
• A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers
• A Clinical Study to Determine the Safety and Efficacy of an Oral Supplementation of Bio-Immune®for Managing Upper Respiratory Tract Infection and Its Symptoms.
• A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
• A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19
• A Combinatorial Biomarker for Infection Diagnosis in Children
• A Comparison of Respiratory Sample Collection by a Parent or by a Healthcare Worker
• A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
• A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
• A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia
• A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
• A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
• A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings
• A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases
• A Novel Formulation of Pasteurized Maple Cough Syrup Compared With Placebo on Nocturnal Cough and Sleep Quality in Infants With Upper Respiratory Infection
• A Nutritional Trial on Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda
• A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

Approved drugs (11)

• Amikacin sulfate
• Amoxicillin
• Aztreonam lysine
• Ceftriaxone sodium
• Cephalexin
• Clavulanate potassium
• Clindamycin phosphate
• Levofloxacin
• Minocycline hydrochloride
• Tobramycin
• Vancomycin

Drugs in development (13)

• Acetaminophen Phase 3
• Acetylcysteine Phase 1
• Ascorbic acid Phase 3
• Clavulanic acid Phase 1
• Danirixin Phase 1
• Gepotidacin Phase 1
• Guaifenesin Phase 3
• Moxifloxacin Phase 1
• Pheniramine maleate Phase 3
• Phenylephrine Phase 3
• Phenylephrine hydrochloride Phase 3
• Pseudoephedrine Phase 3
• Spunoleucel Phase 1

Other linked drugs (1)

• Echinacea, unspecified